Loading...
Last update:  December 3, 2017
19:22 +1GMT

Allergenic Molecule  Bos d 8Canis familiarisHomo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE863.48820101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164081.36020100301, Scala E
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE761.30020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE352.86020130605, Simon D
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.00020130912, Lacerda Araujo LM
1.4 - Respiratory Symptoms, Diagnosed2012ItalyIgE7550.26020120821, Liccardi G
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1405.71020130111, Ott H
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1405.71020130111, Ott H
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2010.00020091005, Ott H
1.5 - Atopic Dermatitis, Diagnosed2014NetherlandsIgE21111.80020140331, Rockmann H
1.5 - Atopic Dermatitis, Diagnosed2006SpainIgE6848.50020060324, Kendler M
10.1 - Normal Control2012BelgiumIgE273.70020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
3.1.4 - Source Sensitized (SPT, IgE)2008NetherlandsIgE1338.46020080401, Lam HY
3.1.4 - Source Sensitized (SPT, IgE)2013PolandIgE21220.80020130424, Kaczmarski M
3.1.4 - Source Sensitized (SPT, IgE)2008NetherlandsSPT1127.27020080401, Lam HY
3.2.1 - Source Sensitized (IgE)2012TaiwanIgE19040.53020121008, Chen FM
3.2.1 - Source Sensitized (IgE)2013United StatesIgE342.94020130409, Kennedy JL
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1001.00020111214, Zheng YW
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE224.55020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE372.70220090826, Ebo DG
5.1.1 - Source Exposed (Symptoms)1998FranceIgE9263.000
5.1.1 - Source Exposed (Symptoms)2006ItalyIgE9169.200
5.1.1 - Source Exposed (Symptoms)2006ItalySPT9974.700
5.1.1 - Source Exposed (Symptoms)2003ItalySPT2458.300
5.2.1 - Source Exposed (Symptoms, SPT)2012FranceIgE10100.00020120910, Bernard H
5.2.5 - Source Exposed, Children (Symptoms, IgE)2010JapanIgE11546.60020100309, Nakano T
5.3.1 - Source Exposed (Symptoms, IgE)1996ArgentinaIgE80100.000
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE997.07020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)1999FranceIgE9263.000
5.3.1 - Source Exposed (Symptoms, IgE)2005United StatesIgE200575.20020050605, Shek LP
5.3.1 - Source Exposed (Symptoms, IgE)1996ArgentinaIgE (IB)80100.000
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Austria / Germany / Spain / Italy / FranceIgE7851.30020100923, Hochwallner H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009GermanyIgE6656.70020090520, Schulmeister U
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010ItalyIgE5846.52020100716, DUrbano LE
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008NetherlandsIgE1872.22020080401, Lam HY
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013PolandIgE7926.20020130424, Kaczmarski M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SpainIgE6783.58020100412, Ibero M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2006SpainIgE23479.00020060407, Martorell A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2003ItalySPT1883.300
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008NetherlandsSPT650.00020080401, Lam HY
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SpainSPT6753.73020100412, Ibero M
5.7.2 - Source Exposed (Provocation Test - Ingestion)2002ItalyIgE2065.000
5.7.2 - Source Exposed (Provocation Test - Ingestion)2009PortugalIgE1776.47020090910, Sokolova A
5.7.2 - Source Exposed (Provocation Test - Ingestion)2004ItalyIgE (IB)2090.000
5.7.2 - Source Exposed (Provocation Test - Ingestion)2004ItalySPT2190.500
5.7.2 - Source Exposed (Provocation Test - Ingestion)2002ItalySPT2075.000
6.3 - General Population (Children)2005ItalyIgE2588.100
6.4 - General Population (Aged)2006HungaryIgE1098.30020060731, Bakos N
Developed by
Panservice